{"result": "(\"entity\"<|>BESOUW MTP<|>PERSON<|>Besouw MTP is an author of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology.)\n##\n(\"entity\"<|>KLETA R<|>PERSON<|>Kleta R is an author of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology.)\n##\n(\"entity\"<|>BOCKENHAUER D<|>PERSON<|>Bockenhauer D is an author of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology.)\n##\n(\"entity\"<|>DABROWSKI E<|>PERSON<|>Dabrowski E is an author of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism.)\n##\n(\"entity\"<|>KADAKIA R<|>PERSON<|>Kadakia R is an author of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism.)\n##\n(\"entity\"<|>ZIMMERMAN D<|>PERSON<|>Zimmerman D is an author of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism.)\n##\n(\"entity\"<|>PELLATIER J<|>PERSON<|>Pelletier J is an author of a study on renal tubular acidosis published in Pediatric Review.)\n##\n(\"entity\"<|>GBADEGESIN R<|>PERSON<|>Gbadegesin R is an author of a study on renal tubular acidosis published in Pediatric Review.)\n##\n(\"entity\"<|>STAPLES B<|>PERSON<|>Staples B is an author of a study on renal tubular acidosis published in Pediatric Review.)\n##\n(\"entity\"<|>Bergum D<|>PERSON<|>Bergum D is an author of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica.)\n##\n(\"entity\"<|>LONNEE H<|>PERSON<|>Lonnée H is an author of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica.)\n##\n(\"entity\"<|>HAKLI TF<|>PERSON<|>Hakli TF is an author of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica.)\n##\n(\"entity\"<|>DEMIREL I<|>PERSON<|>Demirel I is an author of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports.)\n##\n(\"entity\"<|>OZER AB<|>PERSON<|>Ozer AB is an author of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports.)\n##\n(\"entity\"<|>BAYAR MK<|>PERSON<|>Bayar MK is an author of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports.)\n##\n(\"entity\"<|>ERHAN OL<|>PERSON<|>Erhan OL is an author of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports.)\n##\n(\"entity\"<|>LI C<|>PERSON<|>Li C is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>WANG W<|>PERSON<|>Wang W is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>SUMMER SN<|>PERSON<|>Summer SN is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>WESTFALL TD<|>PERSON<|>Westfall TD is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>BROOKS DP<|>PERSON<|>Brooks DP is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>FALK S<|>PERSON<|>Falk S is an author of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology.)\n##\n(\"entity\"<|>MINNITI G<|>PERSON<|>Minniti G is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"entity\"<|>OSTI M<|>PERSON<|>Osti M is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"entity\"<|>JAFFRAIN-REA ML<|>PERSON<|>Jaffrain-Rea ML is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"entity\"<|>ESPOTITO V<|>PERSON<|>Esposito V is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"entity\"<|>CANTORE G<|>PERSON<|>Cantore G is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"entity\"<|>MAURIZI ENRICI R<|>PERSON<|>Maurizi Enrici R is an author of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology.)\n##\n(\"relationship\"<|>BESOUW MTP<|>KLETA R<|>Both are authors of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology<|>7)\n##\n(\"relationship\"<|>BESOUW MTP<|>BOCKENHAUER D<|>Both are authors of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology<|>7)\n##\n(\"relationship\"<|>KLETA R<|>BOCKENHAUER D<|>Both are authors of a study on Bartter and Gitelman syndromes published in Pediatric Nephrology<|>7)\n##\n(\"relationship\"<|>DABROWSKI E<|>KADAKIA R<|>Both are authors of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism<|>7)\n##\n(\"relationship\"<|>DABROWSKI E<|>ZIMMERMAN D<|>Both are authors of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism<|>7)\n##\n(\"relationship\"<|>KADAKIA R<|>ZIMMERMAN D<|>Both are authors of a study on diabetes insipidus in infants and children published in Best Practice & Research Clinical Endocrinology & Metabolism<|>7)\n##\n(\"relationship\"<|>PELLATIER J<|>GBADEGESIN R<|>Both are authors of a study on renal tubular acidosis published in Pediatric Review<|>7)\n##\n(\"relationship\"<|>PELLATIER J<|>STAPLES B<|>Both are authors of a study on renal tubular acidosis published in Pediatric Review<|>7)\n##\n(\"relationship\"<|>GBADEGESIN R<|>STAPLES B<|>Both are authors of a study on renal tubular acidosis published in Pediatric Review<|>7)\n##\n(\"relationship\"<|>Bergum D<|>LONNEE H<|>Both are authors of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica<|>7)\n##\n(\"relationship\"<|>Bergum D<|>HAKLI TF<|>Both are authors of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica<|>7)\n##\n(\"relationship\"<|>LONNEE H<|>HAKLI TF<|>Both are authors of a study on oxytocin infusion and its effects published in Acta Anaesthesiologica Scandinavica<|>7)\n##\n(\"relationship\"<|>DEMIREL I<|>OZER AB<|>Both are authors of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports<|>7)\n##\n(\"relationship\"<|>DEMIREL I<|>BAYAR MK<|>Both are authors of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports<|>7)\n##\n(\"relationship\"<|>OZER AB<|>BAYAR MK<|>Both are authors of a case report on TURP syndrome and severe hyponatremia published in BMJ Case Reports<|>7)\n##\n(\"relationship\"<|>LI C<|>WANG W<|>Both are authors of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology<|>7)\n##\n(\"relationship\"<|>LI C<|>SUMMER SN<|>Both are authors of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology<|>7)\n##\n(\"relationship\"<|>WANG W<|>SUMMER SN<|>Both are authors of a study on the molecular mechanisms of the antidiuretic effect of oxytocin published in the Journal of the American Society of Nephrology<|>7)\n##\n(\"relationship\"<|>MINNITI G<|>OSTI M<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>MINNITI G<|>JAFFRAIN-REA ML<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>OSTI M<|>JAFFRAIN-REA ML<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>MINNITI G<|>ESPOTITO V<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>OSTI M<|>ESPOTITO V<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>JAFFRAIN-REA ML<|>ESPOTITO V<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>MINNITI G<|>MAURIZI ENRICI R<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>OSTI M<|>MAURIZI ENRICI R<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n##\n(\"relationship\"<|>JAFFRAIN-REA ML<|>MAURIZI ENRICI R<|>Both are authors of a study on long-term follow-up results of postoperative radiation therapy for Cushing’s disease published in the Journal of Neuro-Oncology<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: -                                La irrigación con soluciones hipotónicas durante la cirugía prostática transuretral puede\n         pico) y anfotericina.                                                                                                     asociar una excesiva absorción de agua a través de las venas prostáticas, llevando a hipo-\n         El diagnóstico de acidosis tubular renal requiere la medición del pH urinario y la excreción                              natremia dilucional aguda con riesgo de edema cerebral y parada cardiorrespiratoria\n         de amonio. Si el pH urinario es de 5,5 o superior apoya el diagnóstico de acidosis tubular                                El consumo de éxtasis o metanfetamina se asocia a hiponatremia aguda y grave (Na en\n         renal distal, mientras que es variable en el caso de la proximal.                                                         plasma < 120 mmol/l) puesto que aumenta la liberación inapropiada de AVP en la neurohi-\n         Estas dos opciones quedan descartadas puesto que los pacientes con acidosis tubular                                       pófisis (a través de un aumento de dopamina y noradrenalina presináptica), así como al au-\n         renal no realizan deshidratación hipernatrémica ni poliuria al presentar una secreción y                                  mento marcado de la sed, la intensa diaforesis y los sofocos inducidos por la droga. Es, por\n         acción a nivel renal de la AVP normal. Un pH normal o casi normal (7,34) tampoco cuadraría                                tanto, una droga capaz de incrementar de manera marcada los niveles de AVP plasmáticos\n         con una acidosis tubular renal.                                                                                           e inducir la ingesta de grandes cantidades de agua. El riesgo de mortalidad es especialmen-\n                                                                                                                                   te alto en mujeres (menor capacidad adaptativa cerebral por menor volumen intracraneal).\n         Referencias:\n         • Besouw MTP, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: Questions of class. Pediatr Nephrol. 2019 Oct 29.   Finalmente, la oxitocina posee efecto antidiurético al actuar sobre los receptores V2 de la\n         • Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants and children. Best Pract Res Clin Endocrinol Metab.  AVP, tal como muestra los casos clínicos publicados con hiponatremia aguda durante el\n           2016;30(2):317-28.\n         • Pelletier J, Gbadegesin R, Staples B. Renal Tubular Acidosis. Pediatr Rev. 2017;38(11):537-9.                           expulsivo, así como los modelos animales en los que el bloqueo del receptor V2 con fárma-\n                                                                                                                                   cos antagonistas de la AVP normaliza la natremia en ratas con hiponatremia inducida por\n                                                                                                                                   oxitocina.\n     48  Una de las siguientes situaciones no se asocia al desarrollo de hiponatremia aguda\n         (<48 h). Señálela:                                                                                                        Referencias:\n                                                                                                                                   • Bergum D, Lonnée H, Hakli TF. Oxytocin infusion: acute hyponatraemia, seizures and coma. Acta Anaesthesiol Scand. 2009;53(6):826-7.\n                                                                                                                                   • Demirel I, Ozer AB, Bayar MK, Erhan OL. TURP syndrome and severe hyponatremia under general anaesthesia. BMJ Case Rep. 2012\n         A. Cirugía de resección prostática.                                                                                         Nov 19;2012. pii: bcr-2012-006899.\n         B. Consumo de éxtasis/metanfetamina.                                                                                      • Li C, Wang W, Summer SN, Westfall TD, Brooks DP, Falk S, et al. Molecular Mechanisms of Antidiuretic Effect of Oxytocin. J Am Soc\n                                                                                                                                     Nephrol. 2008;19(2):225-32.\n         C. Radioterapia hipofisaria.                                                                                              • Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G, Maurizi Enrici R. Long-term follow-up results of postoperative radiation\n                                                                                                                                     therapy for Cushing’s disease. J Neurooncol. 2007;84:79.\n         D.  Tratamiento con oxitocina.\n\n\n\n480                                                                                                                                                                                                                                                           481\n---\n                                                                                                                                                                                                                    OBESIDAD,               LÍPIDOS                       8\n                                                                                                                                                                                      Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n     49  Respecto a la diabetes insípida nefrogénica (DIN), indique la afirmación errónea:                                                    50  En ocasiones, en caso de hiponatremia grave, puede ser necesario administrar\n         A. En los niños, la causa más frecuente es la hereditaria.                                                                               suero salino hipertónico (3%). ¿Con cuál de las siguientes maniobras conseguimos\n                                                                                                                                                  una concentración de sodio más cercana al 3%?\n         B. La intoxicación por litio causa DIN.\n         C. La hiper\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}